Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Noscapine
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
AZD0156
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
PBDNJ0803
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
URMC-099-C
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
CHEMBL3752642
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Decylphosphinate
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
CHEMBL1568820
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
N-Nonyl Deoxynojirimycin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Oteseconazole
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
AC1MTT7T
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
Retro-2.1
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/26/2020
RBD-HR nanoparticle vaccine
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/25/2020
GD1-69
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
U18666A
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
Narasin
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
X-206
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020
4-Chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020
4-{[5-(2-Nitrophenyl)-2-furyl] methylene}-3-phenyl-5(4H)-isoxazolone
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020
mRBD
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/23/2020
Luminol sodium salt
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/20/2020